APP and Alzheimer disease: APP/PS1 mice have been extensively used to better understand the pathogenic mechanisms underlying synaptic dysfunction and memory impairment in AD, and to screen new therapeutic approaches (Gong et al., 2006; Perez-Gonzalez et al., 2013; Jiao et al., 2015; Jin et al., 2017).